ArticleMolecular cancer2024

PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer.

Chaohua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.